Zai Lab ZLAB
NASDAQ ZLAB
$26.23 -0.77 (-2.85%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zai Lab (ZLAB) Change in Account Payables (2020 - 2026)

Zai Lab (ZLAB) posted Change in Account Payables of $4.3 million for Q1 2026, down 79.06% sequentially from $20.4 million in Q4 2025, and up 56.65% YoY from $2.7 million in Q1 2025.

Analysis

Zai Lab (ZLAB) Change in Account Payables (2020 - 2026) Analysis & Trends

Zai Lab has reported Change in Account Payables for 7 years, with the latest figure at $4.3 million in Q1 2026.

  • Quarterly Change in Account Payables rose 56.65% year-over-year to $4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.5 million (up 54.65% YoY) and the FY2025 annual result came in at $19.9 million, up 1002.04% from the prior year.
  • Change in Account Payables retreated to $4.3 million in Q1 2026 per ZLAB's latest filing, from $20.4 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $46.3 million in Q4 2023 and troughed at -$28.0 million in Q1 2022.
  • A 5-year average of $294588.2 and a median of $2.7 million in 2025 frame the typical range for Change in Account Payables.
  • The sharpest annual moves came in 2024 and 2025: Change in Account Payables tumbled 3988.69% in 2024, then soared 332.49% in 2025.
  • Over 5 years, Change in Account Payables stood at -$24.9 million in 2022, then jumped by 285.76% to $46.3 million in 2023, then tumbled by 118.91% to -$8.8 million in 2024, then jumped by 332.49% to $20.4 million in 2025, then sank by 79.06% to $4.3 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $4.3 million, $20.4 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Zai Lab 2.94 Bn 2.23 Bn 58.15 Mn -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 4.26 Mn
Dec 31, 2025 20.35 Mn
Sep 30, 2025 -6.90 Mn
Jun 30, 2025 3.75 Mn
Mar 31, 2025 2.72 Mn
Dec 31, 2024 -8.75 Mn
Sep 30, 2024 12.66 Mn
Jun 30, 2024 7.25 Mn
Mar 31, 2024 -13.37 Mn
Dec 31, 2023 46.30 Mn
Sep 30, 2023 -12.53 Mn
Jun 30, 2023 3.36 Mn
Mar 31, 2023 -327,000.00
Dec 31, 2022 -24.92 Mn
Sep 30, 2022 -11.13 Mn
Jun 30, 2022 10.28 Mn
Mar 31, 2022 -28.00 Mn
Dec 31, 2021 74.76 Mn
Sep 30, 2021 -74.22 Mn